Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1987 1
1988 1
1989 1
1990 2
1992 1
1993 3
1994 6
1995 4
1996 4
1997 6
1998 8
1999 11
2000 8
2001 4
2002 9
2003 5
2004 6
2005 3
2006 4
2007 7
2008 3
2009 6
2010 9
2011 16
2012 8
2013 8
2014 7
2015 5
2016 4
2017 9
2018 7
2019 7
2020 4
2021 4
2022 8
2023 6
2024 4
2025 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

188 results

Results by year

Filters applied: . Clear all
Page 1
Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck.
Bonner JA, Harari PM, Giralt J, Azarnia N, Shin DM, Cohen RB, Jones CU, Sur R, Raben D, Jassem J, Ove R, Kies MS, Baselga J, Youssoufian H, Amellal N, Rowinsky EK, Ang KK. Bonner JA, et al. N Engl J Med. 2006 Feb 9;354(6):567-78. doi: 10.1056/NEJMoa053422. N Engl J Med. 2006. PMID: 16467544 Free article. Clinical Trial.
Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival.
Bonner JA, Harari PM, Giralt J, Cohen RB, Jones CU, Sur RK, Raben D, Baselga J, Spencer SA, Zhu J, Youssoufian H, Rowinsky EK, Ang KK. Bonner JA, et al. Lancet Oncol. 2010 Jan;11(1):21-8. doi: 10.1016/S1470-2045(09)70311-0. Epub 2009 Nov 10. Lancet Oncol. 2010. PMID: 19897418 Clinical Trial.
HiJAKing Immunotherapy-Resistant Melanoma for a Cure.
Shi LZ, Shen H, Ojo OA, Bonner JA. Shi LZ, et al. Among authors: bonner ja. Oncologist. 2023 Mar 17;28(3):196-198. doi: 10.1093/oncolo/oyac270. Oncologist. 2023. PMID: 36640142 Free PMC article.
In Regard to Bossi et al.
Fakhry C, Nguyen-Tân PF, Lambert L, Rosenthal DI, Weber RS, Gillison ML, Trotti AM 3rd, Barrett WL, Thorstad WL, Jones CU, Yom SS, Wong SJ, Ridge JA, Rao SSD, Bonner JA, Vigneault E, Raben D, Kudrimoti MR, Harris J, Le QT. Fakhry C, et al. Among authors: bonner ja. Int J Radiat Oncol Biol Phys. 2018 Nov 1;102(3):669-670. doi: 10.1016/j.ijrobp.2018.06.020. Int J Radiat Oncol Biol Phys. 2018. PMID: 30238902 No abstract available.
Laryngeal chondrosarcomas: the Mayo Clinic experience.
Kozelsky TF, Bonner JA, Foote RL, Olsen KD, Kasperbauer JL, McCaffrey TV, Lewis JE, Grill JP. Kozelsky TF, et al. Among authors: bonner ja. J Surg Oncol. 1997 Aug;65(4):269-73. doi: 10.1002/(sici)1096-9098(199708)65:4<269::aid-jso8>3.0.co;2-3. J Surg Oncol. 1997. PMID: 9274792 Review.
p16, HPV, and Cetuximab: What Is the Evidence?
Bonner JA, Mesia R, Giralt J, Psyrri A, Keilholz U, Rosenthal DI, Beier F, Schulten J, Vermorken JB. Bonner JA, et al. Oncologist. 2017 Jul;22(7):811-822. doi: 10.1634/theoncologist.2016-0433. Epub 2017 May 18. Oncologist. 2017. PMID: 28526718 Free PMC article. Review.
188 results